1099:HKG
Sinopharm Group Co Ltd
14,88Â HK$
arrow_downward
-0,20%(-0,030) 1K
25-sen, 16:08:12 (GMT+8) · HKD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto1099 tikeri uchun statistika yaratilmoqda...
Ochish
14,94Â HK$
Yuqori
14,94Â HK$
Past
14,60Â HK$
Bozor kapitali
46,44Â mlrd
Oʻrtacha hajm
5,24Â mln
Hajmi
1,91Â mln
Dividend
5,31%
Choraklik dividendlar
0,20Â HK$
Eks-dividend sanasi
23-iyn, 2026
P/E koeffitsiyenti
5,59
52 haftalik eng yuqori
22,34Â HK$
52 haftalik eng past
14,60Â HK$
Aksiya boʻyicha daromad
2,66Â HK$
Muomaladagi aksiyalar
1,19Â mlrd
Xodimlar soni
90Â ming
Ochish
14,94Â HK$
Yuqori
14,94Â HK$
Past
14,60Â HK$
Bozor kapitali
46,44Â mlrd
Oʻrtacha hajm
5,24Â mln
Hajmi
1,91Â mln
Dividend
5,31%
Choraklik dividendlar
0,20Â HK$
Eks-dividend sanasi
23-iyn, 2026
P/E koeffitsiyenti
5,59
52 haftalik eng yuqori
22,34Â HK$
52 haftalik eng past
14,60Â HK$
Aksiya boʻyicha daromad
2,66Â HK$
Muomaladagi aksiyalar
1,19Â mlrd
Xodimlar soni
90Â ming
Profil
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Sinopharm Group Co Ltd haqida
CEO-
Xodimlar soni90,4Â ming
Asos solingan2003
Bosh ofislar-
SektorHealth care provider
Veb-saytsinopharm.com